Neoplasms of the Prostate Terminated Phase 2 Trials for CRLX101 (DB05899)

Also known as: Neoplasms of Prostate / Neoplasms, Prostate / Prostate Neoplasm / Neoplasm, Prostate / Prostate Neoplasms / Neoplasm prostate / Neoplasms Prostate / Neoplasm of the prostate / Prostatic Neoplasms / Prostatic neoplasm NOS / Prostate neoplasia / Neoplasm of prostate (disorder) / Malignant tumor of prostate (disorder)

IndicationStatusPhase
DBCOND0080047 (Neoplasms of the Prostate)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03531827Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide TreatmentTreatment